Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway.

MLA

Guo, Songbin, et al. “Anticancer Effects of Brusatol in Nasopharyngeal Carcinoma through Suppression of the Akt/MTOR Signaling Pathway.” Cancer Chemotherapy & Pharmacology, vol. 85, no. 6, June 2020, pp. 1097–108. EBSCOhost, https://doi.org/10.1007/s00280-020-04083-3.

APA

Guo, S., Zhang, J., Wei, C., Lu, Z., Cai, R., Pan, D., Zhang, H., Liang, B., & Zhang, Z. (2020). Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway. Cancer Chemotherapy & Pharmacology, 85(6), 1097–1108. https://doi.org/10.1007/s00280-020-04083-3

Chicago

Guo, Songbin, Jinling Zhang, Cairong Wei, Zhiyong Lu, Rulong Cai, Danqi Pan, Hanbin Zhang, Baoxia Liang, and Zhenfeng Zhang. 2020. “Anticancer Effects of Brusatol in Nasopharyngeal Carcinoma through Suppression of the Akt/MTOR Signaling Pathway.” Cancer Chemotherapy & Pharmacology 85 (6): 1097–1108. doi:10.1007/s00280-020-04083-3.